# US 5,703,060 A · Uses of aloe products in the prevention and treatment of infections and infestations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,703,060 A
- Document ID: US5703060A
- Status: Granted
- Kind: A
- Application number: 08/463,019
- Filed: 1995-06-05
- Granted: 1997-12-30
- Earliest claimed: 1982-05-07
- Assignees: Carrington Laboratories, Inc.
- Inventors: Bill H. McAnalley; Robert H. Carpenter; Harley R. McDaniel
- Web page: https://patentgrep.com/patent/US5703060A

## CPC

- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A23L 2/56: Flavouring or bittering agents (sweeteners A23L2/60)
- A23L 2/78: by ion-exchange
- A61K 8/9728: Fungi, e.g. yeasts
- A61K 8/9794: Liliopsida [monocotyledons]
- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K 31/736: Glucomannans or galactomannans, e.g. locust bean gum, guar gum
- A61K 36/886: Aloeaceae (Aloe family), e.g. aloe vera
- C07H 15/24: Condensed ring systems having three or more rings
- C07H 15/244: Anthraquinone radicals, e.g. sennosides
- C08B 37/00: Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof (cellulose D21; {microbiological processes C12P})
- C08B 37/0087: {Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof}
- A61K 2039/55583: {Polysaccharides}
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Methods of prevention and treatment of infections and infestations in an animal by administering to the animal an effective amount of an acetylated mannan derivative.

## Claims

### Claim 1

A method for preventing an animal from being infected by an infectious organism, comprising:
administering to said animal an amount of acetylated mannan derivative sufficient to prevent infection by said infectious organism.

### Claim 2 (depends on 1)

The method according to claim 1, wherein said acetylated mannan derivative is acemannan.

### Claim 3

A method for treating fungal infestations in an animal comprising:
administering to said animal an amount of acetylated mannan derivative sufficient to provide antifungal activity.

### Claim 4 (depends on 3)

The method according to claim 3, wherein said acetylated mannan derivative is acemannan.

### Claim 5

A method for treating infections in an animal resistant to an anti-infectious drug, comprising:
administering to said animal an amount of the anti-infectious drug and an amount of acetylated mannan derivative to provide anti-infectious activity.

### Claim 6 (depends on 5)

The method according to claim 5, wherein said acetylated mannan derivative is acemannan.